Literature DB >> 9665197

High-resolution allelotype analysis of childhood B-lineage acute lymphoblastic leukemia.

C Chambon-Pautas1, H Cavé, B Gérard, C Guidal-Giroux, M Duval, E Vilmer, B Grandchamp.   

Abstract

Knowledge of the patterns of allelic loss has been useful in identifying tumor suppressor genes in many solid tumors. Although the loss of genetic material in acute lymphoblastic leukemias has been documented by cytogenetic studies and microsatellite typing, a global overview of losses of heterozygosity occurring throughout the genome was not yet available. We have performed a high resolution allelotype analysis in 63 childhood B-lineage acute lymphoblastic leukemia. A total of 247 microsatellite markers, evenly distributed along the autosomes were typed in blast and in remission samples from every patient. An average of 41 patients were informative for each marker. LOH at one or several loci was observed in 41 of the 63 patients (64%). The mean values for the fractional allelic loss (FAL) and the hemizygosity index, calculated for each patient, were 0.03 (range 0 to 0.23) and 0.024 (range 0 to 0.18), respectively. The most frequently involved chromosomal arms were 9p (36%), 12p (31%), 20q (15%), 6q (12%), 5p (10%) and 10p (10%). Three regions on chromosomal arms 9p, 12p and 6q were previously identified as the targets of recurring deletions, the target genes being identified for two of them (9p and 12p). The three new regions defined by this allelotype may contain tumor-suppressor genes implicated in the initiation or progression of childhood B-ALLs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665197     DOI: 10.1038/sj.leu.2401069

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  3 in total

1.  Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays.

Authors:  R Mei; P C Galipeau; C Prass; A Berno; G Ghandour; N Patil; R K Wolff; M S Chee; B J Reid; D J Lockhart
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

2.  Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemia.

Authors:  Robert J Weeks; Ursula R Kees; Sarah Song; Ian M Morison
Journal:  Mol Cancer       Date:  2010-06-24       Impact factor: 27.401

3.  Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL.

Authors:  Natalya Risinskaya; Yana Kozhevnikova; Olga Gavrilina; Julia Chabaeva; Ekaterina Kotova; Anna Yushkova; Galina Isinova; Ksenija Zarubina; Tatiana Obukhova; Sergey Kulikov; Hunan Julhakyan; Andrey Sudarikov; Elena Parovichnikova
Journal:  Genes (Basel)       Date:  2022-02-23       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.